Correction to: Intensive Care Med https://doi.org/10.1007/s00134-020-05991-x
The original version of this article unfortunately contained mistakes. There is an incorrect unit of IL-6 in Fig. 1 and Supplementary Table 1. It should be pg/mL rather than ng/mL. The corrected Fig. 1 and Supplementary Table 1 can be found below. The authors apologize for the mistakes.
Supplementary Table 1: Summary of clinical features and laboratory results of the patients with confirmed COVID-19
Normal Range | Died (N = 68) | Discharged (N = 82) | p-value | |
---|---|---|---|---|
Demographics | ||||
Age, years | 67 (15-81) | 50 (44-81) | <0.001 | |
Sex | ||||
Male | 49 (72%) | 53 (65%) | ||
Female | 19 (28%) | 29 (35%) | ||
Comorbidities | 43 (63%) | 34 (41%) | 0.01 | |
Hypertension | 29 (43%) | 23 (28%) | 0.07 | |
Cardiovascular disease | 13 (19%) | 0 | <0.001 | |
Diabetes | 12 (18%) | 13 (16%) | 0.88 | |
Cerebrovascular disease | 7 (10%) | 5 (6%) | 0.49 | |
Chronic obstructive pulmonary disease | 2 (3%) | 1 (1%) | 0.59 | |
Chronic kidney disease | 2 (3%) | 0 | 0.20 | |
Malignancy | 2 (3%) | 1 (1%) | 0.59 | |
Chronic liver disease | 1 (1%) | 3 (4%) | 0.63 | |
Connective tissue disease | 1 (1%) | 0 | 0.45 | |
Signs and Symptoms | ||||
Fever | 59 (87%) | 68 (83%) | 0.67 | |
Cough | 51 (75%) | 59 (72%) | 0.81 | |
Sputum production | 29 (43%) | 25 (30%) | 0.17 | |
Fatigue | 15 (22%) | 22 (27%) | 0.63 | |
Myalgia | 9 (13%) | 10 (12%) | 1 | |
Haemoptysis | 3 (4%) | 0 | 0.09 | |
Dyspnea | 59 (87%) | 51 (62%) | 0.001 | |
Respiratory failure | 58 (85%) | 13 (16%) | <0.001 | |
ARDS | 55 (81%) | 7 (9%) | <0.001 | |
Acute kidney injury | 21 (31%) | 2 (2%) | <0.001 | |
Infection | 11 (16%) | 1 (1%) | 0.002 | |
Treatments | ||||
ICU admission | 30 (44%) | 11 (13%) | <0.001 | |
High flow nasal cannula | 31 (46%) | 10 (12%) | <0.001 | |
Non-invasive mechanical ventilation | 46 (68%) | 5 (6%) | <0.001 | |
Invasive mechanical ventilation | 25 (37%) | 0 | <0.001 | |
ECMO | 7 (10%) | 0 | 0.003 | |
CRRT | 5 (7%) | 0 | 0.02 | |
Prone position mechanical ventilation | 3 (4%) | 0 | 0.09 | |
Antiviral treatment | 33 (49%) | 55 (67%) | 0.05 | |
Antibiotic treatment | 63 (93%) | 80 (98%) | 0.66 | |
Antifungal treatment | 12 (18%) | 5 (6%) | 0.04 | |
Glucocorticoid treatment | 31 (46%) | 22 (27%) | 0.02 | |
Time from onset of symptom to start of Glucocorticoid treatment, days | 11.7 (6.9) | 11.4 (4.4) | 0.89 | |
Time from hospital admission to start of Glucocorticoid treatment, days | 1.5 (1.2) | 3.2 (2.7) | 0.01 | |
Glucocorticoid treatment duration, days | 7.2 (6.7) | 7.0 (5.0) | 0.92 | |
Supportive therapy | 45 (66%) | 18 (22%) | <0.001 | |
Length of stay, days | 7.4 (5.5) | 12.3 (4.4) | <0.001 | |
Laboratory Findings | ||||
Time from onset of symptom to test, days | 11.6 (6.8) | 9.8 (4.3) | 0.07 | |
White blood cell count, × 109/L | 3.50-9.50 | 10.62 (4.76) | 6.76 (3.49) | <0.001 |
Lymphocyte count, × 109/L | 1.10-3.20 | 0.60 (0.32) | 1.42 (2.14) | <0.001 |
Haemoglobin, g/L | 130.0-175.0 | 127.0 (16.7) | 127.6 (16.3) | 0.82 |
Platelet count, × 109/L | 125.0-350.0 | 173.6 (67.7) | 222.1 (78.0) | <0.001 |
Albumin, g/L | 35.0-52.0 | 28.8 (3.8) | 32.7 (3.8) | <0.001 |
Alanine aminotransferase, U/L | 9.0-50.0 | 170.8 (991.6) | 48.68 (83.1) | 0.35 |
Aspartate aminotransferase, U/L | 15.0-40.0 | 288.9 (1875.5) | 40.7 (57.8) | 0.31 |
Total bilirubin, μmol/L | 0.0-26.0 | 18.1 (10.7) | 12.8 (6.8) | 0.001 |
Blood urea nitrogen, mmol/L | 3.1-8.0 | 8.65 (4.5) | 5.11 (2.1) | <0.001 |
Creatinine, umol/L | 59.0-104.0 | 91.2 (56.2) | 72.1 (22.2) | 0.02 |
Creatine kinase, U/L | 50.0-310.0 | 319.4 (838.5) | 231.7 (862.3) | 0.56 |
Lactate dehydrogenase, U/L | 120.0-250.0 | 905.8 (2619.1) | 297.9 (110.4) | 0.08 |
Cardiac troponin, pg/mL | 2.0-28.0 | 30.3 (151.0) | 3.5 (6.2) | <0.001 |
Myoglobin, ng/mL | 0.0-146.9 | 258.9 (307.6) | 77.7 (136.1) | <0.001 |
C-reactive protein, mg/L | 0.0-5.0 | 126.6 (106.3) | 34.1 (54.5) | <0.001 |
Interleukin-6, pg/mL | 0.0-7.0 | 11.4 (8.5) | 6.8 (3.61) | <0.001 |
Serum ferritin, ng/mL | 21.8-274.7 | 1297.6 (1030.9) | 614.0 (752.2) | <0.001 |
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ruan, Q., Yang, K., Wang, W. et al. Correction to: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 46, 1294–1297 (2020). https://doi.org/10.1007/s00134-020-06028-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-020-06028-z